Serena Williams has announced to the world loud and proud that she's been taking GLP-1 medication in a bid to lose 31 pounds.

While diet and exercise remain the foundation for many, more and more stars are openly admitting to using weight-loss ...

Through innovation, cost discipline, legal action, and competitive pricing, Novo Nordisk has reasserted its leadership in the GLP-1 market. With a robust pipeline and global expansion, NVO is poised ...

A Comeback Fueled by Resilience Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) has been a trailblazer in the GLP-1 drug ...

Mounjaro and other GLP-1 drugs may lower cancer risk in obese patients, according to a new study. Read more here.

After years of struggling with postpartum weight gain despite strict training and healthy eating, the 23-time Grand Slam ...

Fans rubbed their eyes in disbelief after Meghan Trainor shared a video of herself attempting a wild and risky challenge ...

The plant — which was acquired last year by Novo Nordisk and has a history of troubled inspections — was cited for having cat hair, pests, and bacteria, a recent FDA inspection showed.

Tennis champion Serena Williams said Thursday that she is taking weight loss medication after struggling to see results from diet and exercise following the birth of her two daughters, Olympia and ...

GLP-1 drugs for diabetes and weight loss may influence patients’ cancer risk, usually lowering it but sometimes possibly increasing it, new findings suggest.

Daytime TV has gone through many changes — including heartbreaking cancellations and surprising casting swaps — ahead of the ...

Serena Williams finally comes clean about her drastic weight change. She shares she lost 31 pounds through weight loss ...